PharmaCyte Biotech (PMCB) Assets (2011 - 2026)
PharmaCyte Biotech (PMCB) posted Assets of $36.71 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 18.6% from $45.11 million a year earlier and down 21.5% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Assets (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Assets came in at $46.75 million, down 15.3% from FY2025.
- Annual Assets has declined for four consecutive fiscal years, though with a five-year compound annual growth rate of 44.6% (FY2021 to FY2026).
- In prior fiscal years, PharmaCyte Biotech's Assets was $55.17 million in FY2025 (-7.9%), $59.9 million in FY2024 (-18.3%), $73.28 million in FY2023 (-19.1%) and $90.62 million in FY2022.
- The fiscal Q1 2027 figure stands as the lowest quarterly Assets since fiscal Q1 2022.
- On a year-over-year basis, Assets increased in two of the last eight quarters, with an average decline of 14.6%.
- The strongest year-over-year quarter for Assets in the past five years was fiscal Q2 2022, with growth of 932.4%; the weakest was fiscal Q3 2025, with a decline of 38.6%.
- According to Business Quant data, Assets for the three prior fiscal quarters was $46.75 million (Q4 2026), $55.87 million (Q3 2026) and $55.98 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | 36.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 36.71 Mn |
| Apr 30, 2026 | 46.75 Mn |
| Jan 31, 2026 | 55.87 Mn |
| Oct 31, 2025 | 55.98 Mn |
| Jul 31, 2025 | 45.11 Mn |
| Apr 30, 2025 | 55.17 Mn |
| Jan 31, 2025 | 43.83 Mn |
| Oct 31, 2024 | 55.10 Mn |
| Jul 31, 2024 | 70.19 Mn |
| Apr 30, 2024 | 59.90 Mn |
| Jan 31, 2024 | 71.36 Mn |
| Oct 31, 2023 | 78.88 Mn |
| Jul 31, 2023 | 79.88 Mn |
| Apr 30, 2023 | 73.28 Mn |
| Jan 31, 2023 | 77.95 Mn |
| Oct 31, 2022 | 82.35 Mn |
| Jul 31, 2022 | 87.39 Mn |
| Apr 30, 2022 | 90.62 Mn |
| Jan 31, 2022 | 91.94 Mn |
| Oct 31, 2021 | 92.31 Mn |
API Access
PharmaCyte Biotech Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();